{"filings":[{"id":1619396,"accession_number":"0001193125-26-302539","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2026-07-14T11:40:57+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"HCA Q2 prelim revenue $20.23B, EPS $7.62; cuts FY2026 guidance on payer mix shift","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 2026 revenue $20.230B (+8.7% YoY); net income $1.699B ($7.62 diluted EPS) vs $1.653B ($6.83) in Q2 2025.","Adjusted EBITDA $4.027B vs $3.849B; same-facility admissions +2.5%, ER visits +3.6%, but inpatient surgeries -2.3% and outpatient surgeries -3.4%.","Payer mix shift from health insurance exchanges reduced pre-tax income ~$400M in Q2; Medicaid supplemental programs added ~$400M net benefit.","FY2026 guidance cut: revenue $77-79.5B (prev $76.5-80B), EPS $28.70-30.50 (prev $29.10-31.50), Adjusted EBITDA $15.4-16.1B (prev $15.55-16.45B).","Health insurance exchange impact estimate worsened to ($1.0)-($1.2)B from ($600)-($900)M; Medicaid supplemental improved to $300-500M from ($50)-($250)M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1121756,"accession_number":"0001193125-26-275086","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2026-06-18T13:12:19+00:00","items":["5.02"],"status":"ready","headline":"HCA Healthcare EVP & Chief Clinical Officer Michael Cuffe to step down Aug 31, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Michael Cuffe to step down as EVP and Chief Clinical Officer effective August 31, 2026.","He will continue in a transitional role with the company until February 2027.","Eligible for benefits under executive severance policy and applicable incentive plans.","No successor has been named at this time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99249,"accession_number":"0001193125-26-197278","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"HCA Inc. issues $3B in senior notes across three tranches maturing 2031-2036","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $1B of 4.700% notes due 2031, $750M of 5.000% notes due 2033, and $1.25B of 5.300% notes due 2036.","Notes are senior unsecured obligations of HCA Inc., fully guaranteed by parent HCA Healthcare on a senior unsecured basis.","Underwriting agreement signed April 27, 2026 with Citigroup, Barclays, BofA Securities, and J.P. Morgan as representatives.","Interest payable semi-annually on May 15 and Nov 15, beginning Nov 15, 2026.","Change-of-control put at 101% of principal plus accrued interest if accompanied by a qualifying ratings downgrade."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99248,"accession_number":"0001193125-26-187155","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2026-04-28T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"HCA Healthcare shareholders re-elect all nine director nominees; reject two shareholder proposals at 2026 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All nine director nominees elected; votes for ranged from 173.1M (DeParle) to 193.7M (Hazen) shares.","Ratification of Ernst & Young as independent auditor for FY2026 passed with 192.7M for, 17.0M against.","Non-binding advisory vote on named executive officer compensation approved with 182.4M for, 12.8M against.","Shareholder proposal on healthcare consequences report rejected: 21.2M for, 173.3M against.","Shareholder proposal on right to act by written consent rejected: 42.8M for, 152.1M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99247,"accession_number":"0001193125-26-182265","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2026-04-27T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"HCA Inc. proposes senior notes offering; to redeem $2.5B in near-term notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["HCA Inc. proposes public offering of senior notes; terms not yet set.","Net proceeds to be used for general corporate purposes, including repayment of commercial paper and redemption of notes.","HCA Inc. to redeem $1.5B of 5.250% notes due June 2026 and $1.0B of 5.375% notes due Sept 2026.","Redemption conditioned on receipt of net proceeds from offering; redemption date May 27, 2026.","Joint book-running managers: Citigroup, Barclays, BofA, J.P. Morgan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99246,"accession_number":"0001193125-26-174933","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2026-04-24T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Q1 revenue up 4.3% to $19.1B; EPS rises 10.9% to $7.15; declares $0.78 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenues $19.109B, net income $1.620B (+0.6% YoY); diluted EPS $7.15 (+10.9% YoY).","Adjusted EBITDA $3.802B (+1.9%); cash from operations $2.014B (+22.0%).","Same facility admissions +0.9%; equivalent admissions +1.3% vs Q1 2025.","Quarterly cash dividend of $0.78 per share declared, payable June 30, 2026 to holders of record June 16, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":7.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":19109000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115130,"accession_number":"0001193125-26-071880","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"HCA sets 2026 exec comp: CEO target 175% of salary; board member Dennis to retire","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Samuel Hazen target award 175% of base; CFO/COO 125%; other named execs 100%.","Awards weighted 80% on EBITDA, 20% on quality metrics (HAIs, mortality, care experience).","EBITDA payout ranges from 25% (threshold) to 200% (max); quality payout 0% if EBITDA below 90% of target.","Director Robert J. Dennis to retire at April 23, 2026 annual meeting, not standing for re-election.","Awards subject to recoupment under company policy and discretionary recoupment clauses."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115129,"accession_number":"0001193125-26-023323","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2026-01-27T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Healthcare Q4 EPS $8.14 (up 44.6%), revenue $19.5B, $10B buyback authorized","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $19.513B (+6.7% YoY); net income $1.878B (+30.6%); adjusted EBITDA $4.114B (+10.8%).","Diluted EPS $8.14 (+44.6%), adjusted EPS $8.01 (+28.8%); same-facility admissions +2.4%, equivalent admissions +2.5%.","Board authorized new $10B share repurchase program; $750M remained under prior authorization as of Dec 31.","Quarterly dividend raised to $0.78/share, payable March 31, 2026 to holders of record March 17.","2026 guidance: revenue $76.5B-$80B, EPS $29.10-$31.50, adjusted EBITDA $15.55B-$16.45B."],"consensus_eps_estimate":null,"consensus_eps_actual":28.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":75600000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131539,"accession_number":"0001193125-25-260809","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-10-31T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"HCA issues $3.25B senior notes: 4.30% 2030, 4.60% 2032, 4.90% 2035, 5.70% 2055","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$500M 4.30% notes due 2030, $1B 4.60% due 2032, $1B 4.90% due 2035, $750M 5.70% due 2055.","Interest payable semi-annually May 15 and Nov 15, beginning May 15, 2026.","Notes are senior unsecured obligations of HCA Inc., fully guaranteed by HCA Healthcare.","Rank equally with existing senior debt; effectively subordinated to secured debt and structurally subordinated to subsidiary liabilities.","Underwriting led by J.P. Morgan, Citigroup, Mizuho, and Wells Fargo; redemption and change-of-control put at 101%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131538,"accession_number":"0001193125-25-251612","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-10-27T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"HCA subsidiary proposes senior notes offering, plans to redeem $1.5B 5.875% notes due 2026","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["HCA Inc. proposes public offering of senior unsecured notes; terms (maturity, rate, amount) to be set at pricing.","Net proceeds to be used for general corporate purposes, including repayment of $4B commercial paper program and potential redemption of $1.5B 5.875% notes due 2026.","HCA Inc. provides notice of redemption of all $1.5B 5.875% senior notes due 2026, conditioned on receipt of offering proceeds; redemption date Nov 26, 2025.","Joint book-running managers: J.P. Morgan, Citigroup, Mizuho, Wells Fargo.","Offering is made under effective shelf registration statement; copies of preliminary prospectus available from managers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131537,"accession_number":"0001193125-25-249345","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-10-24T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Healthcare Q3 EPS $6.96, revenue $19.2B, raises 2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Diluted EPS $6.96 (up 42.6% YoY); net income $1.643B (up 29.4%).","Revenue $19.161B (+9.6% YoY); Adjusted EBITDA $3.870B (+18.5%).","Same facility admissions +2.1%, same facility equivalent admissions +2.4%.","Quarterly dividend declared: $0.72/share, payable Dec 29 to holders of record Dec 15.","Full-year 2025 guidance raised (specific figures not released)."],"consensus_eps_estimate":null,"consensus_eps_actual":20.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":56087000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148112,"accession_number":"0000950170-25-098578","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-07-25T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Q2 revenue $18.6B (+6.4%), EPS $6.83 (+23.5%); raises 2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $18.605B (+6.4% YoY); net income $1.653B (+13.1% YoY).","Diluted EPS $6.83 (+23.5%); adjusted diluted EPS $6.84 (+24.4%).","Adjusted EBITDA $3.849B (+8.4%); same facility admissions +1.8%.","Quarterly cash dividend declared at $0.72/share, payable Sep 30, record Sep 16.","Company announces it is raising full-year 2025 guidance (specific new figures not provided in filing excerpt)."],"consensus_eps_estimate":null,"consensus_eps_actual":13.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":36926000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148111,"accession_number":"0001193125-25-158208","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-07-11T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"HCA Healthcare appoints John W. Chidsey, III as independent director, effective July 15","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board expands from 9 to 10 directors; Chidsey will serve on Audit & Compliance, Compensation, and Patient Safety & Quality of Care committees.","Chidsey most recently served as global CEO of Subway; previously CEO of Burger King Holdings and senior roles at Cendant and PepsiCo.","He currently serves on the board of Norwegian Cruise Line Holdings, and previously served on boards of Encompass Health, Burger King, and Brinker International.","Appointment fills a newly created directorship per the company's amended certificate of incorporation; no arrangements with any other person."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166868,"accession_number":"0001193125-25-138463","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-06-10T23:59:59+00:00","items":["2.03","8.01"],"status":"ready","headline":"HCA Inc. establishes $4B commercial paper program, guaranteed by HCA Healthcare","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issuer HCA Inc. can issue up to $4B in unsecured commercial paper notes with maturities up to 397 days.","Notes unconditionally guaranteed by parent HCA Healthcare, Inc.","Proceeds used for general corporate purposes; amounts may be borrowed, repaid, and reborrowed.","Notes sold privately in U.S. commercial paper market, not registered under Securities Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166867,"accession_number":"0001193125-25-103953","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-04-29T23:59:59+00:00","items":["5.02","5.07","5.03","9.01"],"status":"ready","headline":"HCA stockholders OK 13.15M share increase for equity plan; officer exculpation amendment passed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved First Amendment to 2020 Stock Incentive Plan, adding 13,150,000 shares (total reserve now 18,542,144).","Amended charter to provide officer exculpation under Delaware law; 190.2M for, 22.1M against.","All nine director nominees elected, including Samuel N. Hazen and Thomas F. Frist III, with >84% support.","Non-management director compensation updated: $130K annual cash retainer, $220K annual equity award, plus committee chair retainers.","Stockholder proposals on golden parachutes, patient safety committee charter, and acquisition strategy all rejected."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166866,"accession_number":"0000950170-25-058334","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-04-25T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Healthcare Q1 revenue $18.3B, EPS $6.45, adjusted EBITDA $3.73B, reaffirms guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $18.321B (+5.7% YoY); net income $1.610B, diluted EPS $6.45 (vs $5.93 prior year).","Adjusted EBITDA $3.733B (+11.3% YoY); same facility admissions +2.6%, ER visits +4.0%.","Cash from ops $1.651B (down from $2.469B); repurchased 7.762M shares for $2.506B.","Declared quarterly dividend $0.72/share, payable June 30 to holders of record June 16.","Reaffirmed full-year 2025 guidance ranges including Adjusted EBITDA and EPS."],"consensus_eps_estimate":null,"consensus_eps_actual":6.45,"consensus_revenue_estimate":null,"consensus_revenue_actual":18321000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184271,"accession_number":"0001193125-25-033430","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-02-24T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"HCA director Crofton to retire at April 2025 annual meeting; exec incentive program adopted","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Meg G. Crofton to retire from HCA board effective April 24, 2025 annual meeting.","Compensation Committee adopted 2025 Executive Officer Performance Excellence Program for named execs.","CEO Hazen target award 175% of base salary; CFO Marks and COO Foster 125%.","Awards weighted 80% EBITDA and 20% quality metrics (HAI, sepsis, mortality, care experience).","EBITDA portion: threshold 25%, target 100%, max 200% of target; quality metrics similar but no payout if EBITDA <90% of target."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184270,"accession_number":"0001193125-25-031999","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-02-21T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"HCA Inc. issues $5.25B of senior notes across six tranches maturing 2028-2055","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Total $5.25B: $700M 5.000% notes due 2028, $300M floating-rate notes due 2028, $750M 5.250% due 2030.","Additional $750M 5.500% due 2032, $1.5B 5.750% due 2035, and $1.25B 6.200% due 2055.","Notes are senior unsecured obligations of HCA Inc., fully guaranteed by HCA Healthcare on a senior unsecured basis.","Issued under shelf registration; proceeds for general corporate purposes (per typical use).","Underwriting agreement with BofA, Barclays, Citi, J.P. Morgan, Mizuho, Wells Fargo dated Feb 18, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184269,"accession_number":"0001193125-25-030833","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-02-20T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"HCA enters $8.0B unsecured revolver, terminates secured credit facilities","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $8.0B senior unsecured revolving credit facility with 5-year maturity dated Feb 20, 2025.","Borrower used facility to repay $3.5B revolver and $1.238B term loan under prior secured facilities.","Interest rate initially Term SOFR + 1.250% plus 0.10% credit spread adjustment.","Financial covenant: leverage ratio ≤ 4.50:1 (step-up to 5.00:1 after material acquisition).","Proceeds to be used for general corporate purposes; facility is unsecured and not guaranteed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184268,"accession_number":"0001193125-25-028231","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-02-18T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"HCA Inc. proposes public offering of senior notes; plans $8B unsecured credit facility to replace secured facilities","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["HCA subsidiary HCA Inc. proposes offering of senior notes; final terms (maturity, rate, amount) depend on market conditions.","Issuer intends to refinance $3.5B cash flow and $4.5B ABL secured credit facilities with new $8B senior unsecured revolving credit facility.","New facility has 5-year term, leverage covenant of 4.50:1.00 (step-up to 5.00 after material acquisition), and initial rate of Term SOFR + 1.250% plus 0.10% credit spread.","Net proceeds from note offering will be used for general corporate purposes, which may include repaying $2.95B ABL borrowings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184267,"accession_number":"0000950170-25-008608","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-01-24T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Q4 revenue $18.3B, EPS $5.63; 2025 EPS guidance $24.05-$25.85; $10B buyback authorized","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $18.285B (+5.7% YoY); net income $1.438B ($5.63 diluted EPS) vs $1.607B ($5.93) in 4Q23; includes $0.60/sh hurricane impact.","Adjusted EBITDA Q4 $3.712B vs $3.618B; same-facility admissions +3.0%, equivalent admissions +3.1%.","Full year 2024 revenue $70.6B, net income $5.76B ($22.00 EPS) vs $5.24B ($18.97) in 2023; Adjusted EBITDA $13.88B.","2025 guidance: revenue $72.8-$75.8B, net income $5.85-$6.29B, EPS $24.05-$25.85, capex $5.0-$5.2B.","Board authorized $10B share repurchase; quarterly dividend $0.72/share payable Mar 31 to record Mar 17."],"consensus_eps_estimate":null,"consensus_eps_actual":22.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":70603000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200870,"accession_number":"0000950170-24-117215","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2024-10-25T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Healthcare Q3 2024 revenue $17.49B, EPS $4.88; reaffirms FY guidance but sees lower half due to hurricanes","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $17.487B (up 7.9% YoY), net income $1.270B (up 17.7%), diluted EPS $4.88 vs $3.91.","Adjusted EBITDA $3.267B, up from $2.880B; same facility admissions +4.5%, ER visits +4.6%.","Hurricane Helene impact $50M ($0.15/sh) in Q3; Q4 estimate $200-300M ($0.60-0.90/sh) from Helene and Milton.","Reaffirmed FY 2024 guidance, expects results in lower half; capex now ~$5B.","Declared quarterly dividend $0.66 per share payable Dec 27, 2024 to holders of record Dec 13, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":16.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":52318000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216861,"accession_number":"0001193125-24-198927","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2024-08-12T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"HCA Healthcare issues $3B in senior notes across three tranches with rates 5.45%-5.95%","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$3B total: $750M 5.45% notes due 2031 (now $1.75B total), $1.25B 5.45% notes due 2034, $1B 5.95% notes due 2054.","Notes are senior unsecured obligations of HCA Inc., fully guaranteed by HCA Healthcare.","Interest payable semi-annually; first payments Oct 2024 (2031) and Mar 2025 (2034/2054).","Optional redemption permitted; change-of-control repurchase at 101% of principal plus accrued interest.","Indentures include customary covenants limiting liens, sale-leaseback, and mergers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216860,"accession_number":"0001193125-24-197060","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"HCA Healthcare issues $3B senior notes in three tranches; 2031 notes fungible with existing","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$750M of 5.450% Senior Notes due 2031, issued as additional notes under existing indenture and fungible with prior $1B issue.","$1.25B of 5.450% Senior Notes due 2034; $1B of 5.950% Senior Notes due 2054.","Notes are senior unsecured obligations guaranteed by HCA Healthcare, Inc. (parent).","Issuance via underwriting agreement with Citigroup, BofA, J.P. Morgan, and Wells Fargo as representatives."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216859,"accession_number":"0001193125-24-182591","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2024-07-23T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Q2 2024 rev $17.49B, EPS $5.53, raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $17.492B (+10.3% YoY); net income $1.461B ($5.53 diluted EPS) vs $1.193B ($4.29).","Adjusted EBITDA $3.550B (+16.2% YoY); same facility admissions +5.8%, ER visits +5.5%.","FY2024 guidance raised: rev $69.75-71.75B (prev $67.75-70.25B), EPS $21.60-22.80 (prev $19.70-21.20).","Board declared quarterly dividend $0.66/share, payable Sept 30, record Sept 16.","Repurchased 4.217M shares at $1.367B in Q2; $4.228B remaining under buyback authorization."],"consensus_eps_estimate":null,"consensus_eps_actual":11.47,"consensus_revenue_estimate":null,"consensus_revenue_actual":34831000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236596,"accession_number":"0001193125-24-125204","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2024-04-30T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"HCA Healthcare CFO William Rutherford to retire May 1; Christopher Wyatt named principal accounting officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["William B. Rutherford retires as EVP/CFO effective May 1, 2024; Christopher Wyatt succeeds as principal accounting officer.","Annual meeting elects all 10 director nominees and ratifies Ernst & Young as auditor for 2024.","Say-on-pay advisory vote approved with 217M votes for and 13.5M against; one-year frequency adopted.","Stockholder proposals on abortion risk, patient feedback, and maternal health outcomes all defeated by wide margins."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236595,"accession_number":"0001193125-24-115857","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2024-04-26T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Q1 revenue up 11% to $17.34B, EPS $5.93; reaffirms FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $17.339B (+11.2% YoY); net income $1.591B ($5.93 diluted EPS) vs $1.363B ($4.85).","Adjusted EBITDA $3.353B; same facility admissions +6.2%, equivalent admissions +5.2%.","Cash from operations $2.469B; repurchased 3.894M shares for $1.180B; $5.595B remaining.","Board declared $0.66/share dividend, payable June 28 to holders of record June 14.","Reaffirmed 2024 guidance; includes $201M gain on sale of California hospital."],"consensus_eps_estimate":null,"consensus_eps_actual":5.93,"consensus_revenue_estimate":null,"consensus_revenue_actual":17339000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254228,"accession_number":"0001193125-24-046240","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2024-02-26T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"HCA appoints McAlevey as EVP – Chief Legal & Admin Officer; CFO Rutherford to retire May 1","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Hazen target award 170% of base salary; COO Foster 125%; CFO Rutherford retiring May 1, 2024, not participating.","Michael R. McAlevey appointed EVP – Chief Legal & Admin Officer effective April 1, 2024; base salary $990,000; equity award $500,000.","Executive Officer PEP: 80% EBITDA-weighted, 20% quality metrics; payout range 25%-200% of target.","PEP quality metrics: Healthcare-Associated Infections & Sepsis (30%), Complication & Mortality (30%), Care Experience (40%).","If actual EBITDA <90% of target, no quality payout; clawback and adjustment provisions apply."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254224,"accession_number":"0001193125-24-046248","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K/A","filed_at":"2024-02-26T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"HCA Healthcare sets CFO Michael Marks' 2024 PEP award at 65% of base, rising to 110%","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Compensation Committee approved 2024 Executive Officer PEP for CFO Michael A. Marks, effective May 1, 2024.","PEP award opportunity initially 65% of base salary, increases to 110% as of effective date.","Award weighted 80% on EBITDA targets and 20% on quality metrics (HAI/Sepsis 30%, Complication/Mortality 30%, Care Experience 40%)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254227,"accession_number":"0001193125-24-044555","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2024-02-23T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"HCA issues $4.5B of senior notes across four tranches (2031-2064)","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$1.0B of 5.450% notes due 2031, $1.3B of 5.600% notes due 2034, $1.5B of 6.000% notes due 2054, $0.7B of 6.100% notes due 2064.","Notes are senior unsecured obligations guaranteed by HCA Healthcare Inc.; rank equally with existing senior debt.","Interest payable semi-annually starting Oct 1, 2024; notes redeemable at any time at specified prices.","Proceeds not specified; typical for general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254226,"accession_number":"0001193125-24-040747","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2024-02-21T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"HCA Healthcare issues $4.5B senior notes in four tranches with maturities from 2031 to 2064","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$1.0B of 5.450% notes due 2031, $1.3B of 5.600% notes due 2034.","$1.5B of 6.000% notes due 2054, $700M of 6.100% notes due 2064.","Notes are senior unsecured obligations guaranteed by HCA Healthcare, Inc.","Issued via underwritten public offering under existing shelf registration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254225,"accession_number":"0001193125-24-018748","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2024-01-30T23:59:59+00:00","items":["2.02","5.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Healthcare Q4 revenue up 11.6% to $17.3B; FY2024 EPS guidance $19.70-$21.20; CFO succession announced","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2023 revenue $17.303B (+11.6% YoY); net income $1.607B ($5.93 diluted EPS) vs $2.081B ($7.28) in Q4 2022, which included $1.326B gain.","Adjusted EBITDA $3.618B (up from $3.179B); same facility admissions +3.1%, equivalent admissions +3.9%.","FY2024 guidance: revenue $67.75-$70.25B, Adjusted EBITDA $12.85-$13.55B, diluted EPS $19.70-$21.20; capex $5.1-$5.3B.","Board authorized additional $6B share repurchase program; quarterly dividend declared at $0.66 per share (unchanged).","CFO Bill Rutherford retiring May 1, 2024; succeeded by Mike Marks, current SVP Finance."],"consensus_eps_estimate":null,"consensus_eps_actual":18.97,"consensus_revenue_estimate":null,"consensus_revenue_actual":64968000000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":271714,"accession_number":"0001193125-23-274071","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2023-11-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"HCA targets 4-6% EBITDA, 8-12% EPS growth over 5 yrs; 2024 within ranges","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Adjusted EBITDA growth target of 4% to 6% annually over next five years.","Diluted EPS growth target of 8% to 12% annually over next five years.","2024 expectations fall within those ranges, after resolving Q1 commercial payer dispute.","More detailed 2024 guidance to be provided in January year-end call."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":271713,"accession_number":"0001193125-23-261204","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2023-10-24T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Healthcare Q3 revenue $16.21B, EPS $3.91; FY 2023 guidance revised; dividend $0.60","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $16.213B (+8.3% YoY); net income $1.079B ($3.91 diluted EPS, flat vs $3.91 prior year).","Adjusted EBITDA $2.88B, down from $2.902B; same-facility admissions +3.4%, equivalent admissions +4.1%.","FY 2023 guidance revised: revenue $63.5-$64.5B, adjusted EBITDA $12.3-$12.6B, EPS $17.80-$18.50.","Board declared $0.60/share dividend payable Dec 28 to holders of record Dec 14; Q3 buyback $1.14B, $1.685B remaining.","CEO cited solid demand but Valesco physician staffing JV performed below expectations."],"consensus_eps_estimate":null,"consensus_eps_actual":13.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":47665000000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":288562,"accession_number":"0001193125-23-195360","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2023-07-27T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Healthcare Q2 2023 revenue $15.86B; EPS $4.29; raises 2023 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $15.861B, up 7% YoY; net income $1.193B, diluted EPS $4.29 (vs $3.90).","Adjusted EBITDA $3.056B; same facility admissions +2.2%, equivalent admissions +3.7%.","2023 guidance raised: revenue $63.25-$64.75B, EPS $17.70-$18.90.","Quarterly dividend $0.60/share, payable Sept 29 to holders of record Sept 15.","Repurchased 3.3M shares for $915M in Q2; $2.825B remaining authorization."],"consensus_eps_estimate":null,"consensus_eps_actual":9.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":31452000000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":288561,"accession_number":"0001193125-23-184269","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2023-07-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"HCA Healthcare reports data security incident affecting patient contact and appointment information","summary_kind":"llm","event_type":"cyber","confidence":"high","bullets":["Unknown unauthorized party posted patient names, email, phone, birth date, gender, service date, and appointment location on an online forum.","Excluded data: clinical treatment/diagnosis, payment info, passwords, driver's license, and Social Security numbers.","Theft occurred from an external storage location used to format email messages; no disruption to patient care or operations.","Company reported incident to law enforcement, retained forensic advisors, disabled access, and will offer credit monitoring to impacted patients.","HCA believes the incident will not materially impact its business, operations, or financial results based on current information."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":309107,"accession_number":"0001193125-23-155487","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2023-05-26T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"HCA reorganizes operations into three geographic groups (National, American, Atlantic) effective Jan 1, 2023","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Segments changed from two to three groups; historical segment data in 2022 10-K retrospectively revised.","National, American, and Atlantic Groups replace prior two-group structure; no change to consolidated results.","Revised segment financials filed as Exhibit 99.1; all other 2022 10-K information unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":309106,"accession_number":"0001193125-23-136049","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2023-05-04T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"HCA Healthcare issues $3.25B in three tranches of senior notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $1B 5.200% notes due 2028, $1.25B 5.500% notes due 2033, $1B 5.900% notes due 2053.","Notes are senior unsecured obligations of HCA Inc., fully guaranteed by HCA Healthcare, Inc.","Interest payable semi-annually June 1 and Dec 1 starting Dec 1, 2023.","Issuer may redeem notes at any time at specified redemption prices; change-of-control put at 101%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":309105,"accession_number":"0001193125-23-131536","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2023-05-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"HCA Healthcare issues $3.25B senior notes in three tranches","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$1.0B of 5.200% Senior Notes due 2028, $1.25B of 5.500% due 2033, $1.0B of 5.900% due 2053.","Notes guaranteed on a senior unsecured basis by parent HCA Healthcare, Inc.","Issuance by subsidiary HCA Inc. under existing shelf registration statement.","Underwriting agreement with BofA Securities, Citigroup, J.P. Morgan, Wells Fargo."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":309104,"accession_number":"0001193125-23-110578","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2023-04-21T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"HCA Healthcare shareholders approve 2023 ESPP and re-elect all directors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved the 2023 Employee Stock Purchase Plan, which reserves 10M shares for employee purchases.","Exercise price for ESPP set at 90% of closing market price on exercise date; plan effective April 19, 2023.","All 10 director nominees re-elected; say-on-pay advisory resolution passed with 230.6M votes for.","Two shareholder proposals (political spending disclosure and Patient Safety committee charter) rejected.","Ratification of Ernst & Young as auditor approved with 240.7M votes for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":309103,"accession_number":"0001193125-23-109258","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2023-04-21T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Healthcare Q1 EPS $4.85 beats prior year; raises 2023 revenue and profit guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenues $15.591B (up 4.3% YoY); net income $1.363B, diluted EPS $4.85 vs $4.14.","Adjusted EBITDA $3.172B vs $2.944B; same facility admissions +4.4%, equivalent admissions +7.5%.","Board declared $0.60/share dividend payable June 30, 2023, record June 16.","Repurchased 3.34M shares for $846M in Q1; $3.74B remaining under authorization.","2023 guidance raised: revenue $62.5-64.5B; EPS $17.25-18.55; Adjusted EBITDA $12.1-12.7B."],"consensus_eps_estimate":null,"consensus_eps_actual":4.85,"consensus_revenue_estimate":null,"consensus_revenue_actual":15591000000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":309102,"accession_number":"0001193125-23-094138","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2023-04-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"HCA Healthcare 2023 Senior Officer PEP: CEO target 170% of base, 80% EBITDA weight","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Samuel N. Hazen target award 170% of base salary; CFO William B. Rutherford and COO Jon M. Foster each 125%.","Awards weighted 80% on EBITDA targets and 20% on quality metrics (Healthcare-Associated Infections, Complication/Mortality, Care Experience).","EBITDA portion: threshold 25% payout, target 100%, maximum 200% of target; quality portion: 0% at threshold, 200% at max.","No quality payout if actual EBITDA below 90% of target; awards paid in cash within 2.5 months after fiscal year-end.","Program includes clawback provisions for restatements or misconduct; employment through year-end required for payout."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327865,"accession_number":"0001193125-23-019137","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K/A","filed_at":"2023-01-30T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"HCA Healthcare details COO Foster's compensation: base to $1M, $3.75M equity grant","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Base salary increased from $918,596 to $1,000,000 effective January 1, 2023.","Long-term equity award of $3,750,000 target value: 50% stock appreciation rights (4-year vest), 50% performance share units (3-year EPS goal).","Equity grant constitutes Mr. Foster's annual award; approved by Compensation Committee on January 24, 2023.","Compensation changes reflect role as Executive Vice President and Chief Operating Officer."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327867,"accession_number":"0001193125-23-016833","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2023-01-27T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Healthcare Q4 net income $2.08B ($7.28 EPS); revenue $15.5B; new $3B buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $15.50B (+2.9% YoY); net income $2.08B ($7.28 diluted EPS) incl $1.33B facility-sale gains.","Adjusted EBITDA $3.18B vs $3.15B YoY; same-facility admissions +2.9%, ER visits +11.4%.","FY2022 revenue $60.23B, net income $5.64B ($19.15 EPS); adjusted EBITDA $12.07B.","Board authorized new $3B share repurchase program; declared quarterly dividend of $0.60/sh payable Mar 31.","2023 guidance: revenue $61.5-63.5B, EPS $16.40-17.60, capex ~$4.3B."],"consensus_eps_estimate":null,"consensus_eps_actual":19.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":60233000000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327866,"accession_number":"0001193125-23-001579","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2023-01-04T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"HCA Healthcare amends credit facilities: revolver increased to $3.5B, LIBOR replaced with Term SOFR","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Revolving credit commitments under Cash Flow Credit Facility raised from $2.0B to $3.5B; maturity extended to June 30, 2026.","LIBOR replaced with Term SOFR plus 0.10% per annum credit spread adjustment for both facilities.","$492.5M outstanding Tranche B term loans repaid using ABL facility proceeds and cash on hand.","ABL Credit Facility also amended to adopt Term SOFR as reference rate; no additional indebtedness incurred."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345544,"accession_number":"0001193125-22-308372","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2022-12-19T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"HCA Healthcare amends bylaws to update director nomination and proxy solicitation requirements","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board adopted Third Amended and Restated Bylaws effective December 19, 2022.","Amendment revises Article II, Section 11 to require compliance with SEC Rule 14a-19 for director nominations and proxy solicitations.","Technical, ministerial, and conforming changes made to align with recent Delaware General Corporation Law amendments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345543,"accession_number":"0001193125-22-269593","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2022-10-26T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"HCA Healthcare promotes Jon Foster to EVP & COO; creates third operating group","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jon Foster, previously President of American Group, named EVP & COO effective January 1, 2023.","Three operating groups (American, National, Atlantic) each with five domestic divisions created.","Erol Akdamar promoted to President – American Group; Tim McManus to President – National Group; Richard Hammett to President – Atlantic Group.","Multiple division president and CFO promotions announced, including Brian Cook, Jackie Van Blaricum, and others.","Organizational change designed to enhance alignment, improve long-term performance, and increase decision-making agility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345542,"accession_number":"0001193125-22-266319","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2022-10-21T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Healthcare Q3 revenue down 2% to $14.97B; net income $1.13B ($3.91 EPS)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue fell 2% YoY to $14.97B; net income $1.13B ($3.91 EPS) vs $2.27B ($7.00 EPS) prior year which included $1.05B sale gains.","Adjusted EBITDA $2.902B vs $3.224B; same-facility admissions -1.5%, equivalent admissions +2.3%.","Hurricane Ian impact estimated at $35M in additional expenses and lost revenues, prior to insurance.","Operating cash flow $3.020B; repurchased 3.36M shares for $698M; $3.1B remaining authorization.","Quarterly dividend $0.56/share, payable Dec 28, 2022 to holders of record Dec 14."],"consensus_eps_estimate":null,"consensus_eps_actual":11.97,"consensus_revenue_estimate":null,"consensus_revenue_actual":44736000000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":361989,"accession_number":"0001193125-22-222847","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2022-08-17T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"HCA President – National Group Charles J. Hall to retire on Dec 31, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Charles J. Hall, President – National Group, will retire effective December 31, 2022.","The Company will select a successor in due course; no replacement named.","Hall informed the Company of his retirement on August 15, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":361988,"accession_number":"0001193125-22-199606","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2022-07-22T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Healthcare Q2 2022 net income down 20% to $1.155B; EPS $3.90 vs $4.36 YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $14.820B (+2.7% YoY); net income $1.155B ($3.90 EPS) vs $1.450B ($4.36) in Q2 2021.","Adjusted EBITDA $3.042B (-5.5% YoY); same facility admissions -1.2%, equivalent admissions +0.5%.","Operating cash flow $1.630B vs $2.251B in Q2 2021; capital expenditures $1.080B (ex-acquisitions).","Repurchased 12.23M shares for $2.682B in Q2; $3.803B remaining under repurchase authorization.","Board declared $0.56 quarterly dividend, payable Sept 30 to holders of record Sept 16."],"consensus_eps_estimate":null,"consensus_eps_actual":8.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":29765000000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-07-22T23:59:59+00:00|361988"}